Health
Showing 49–59 of 59 results
| Title & Subtitle | Abstract | Contributors | Pages | Year | Purchase |
|---|---|---|---|---|---|
|
From ![]() The Collective Action ProblemFrom: Medicare |
Outlines that the real issue is not whether for-profit private care is the answer, but rather how we can find a collective answer to achieve the vision of “Medicare 2.” Looks at the … | Robert McMurtry | 8 | 2007 | $0.80 Add |
|
From ![]() The Continental Deep Integration ThreatFrom: Medicare |
Looks at the threat to public health caused by the idea of continental deep integration. Looks at the Security and Prosperity Partnershipt, SMART Regulations, trade investment and labour mobility … | Maude Barlow | 6 | 2007 | $0.60 Add |
|
From ![]() The Douglas Legacy and the Future of MedicareFrom: Medicare |
Discusses Tommy Douglas’s lasting legacy as a political leader through his introduction of universal health care | Greg; Marchildon | 8 | 2007 | $0.80 Add |
|
From ![]() The Electronic Health Record:The Neglected Key to Saving Medicare From: Medicare |
Examines the Electronic Health Record and its role to play in the realization of first-rate, safe, efficient, and just health care | Steven Lewis | 8 | 2007 | $0.80 Add |
|
From ![]() The Struggle — at Home and in the World — for Health Care as a Human RightFrom: Medicare |
discusses the need for social justice and equality in terms of public health and democratic socialism | Stephen Lewis | 13 | 2007 | $1.30 Add |
|
From ![]() The TPP and Health Care |
Explores the implications of the TPP for public health care resulting from the agreement’s provisions on intellectual property, services and investment. | Scott Sinclair | 26 | 2016 | $2.60 Add |
|
From ![]() The TPP and the Regulation of Medicines in Canada |
Explores the implications of the TPP for drug costs resulting from the agreement’s provisions on intellectual property, services and investment. | Joel Lexchin | 18 | 2016 | $1.80 Add |
|
From ![]() The Truth about the Drug CompaniesFrom: Medicare |
Examines the pharmaceutical industry and the paradox of what the drug companies say vs. what really happens. Concludes with a recommendation for pharmacare in Canada | Marcia Angell | 7 | 2007 | $0.70 Add |
|
From ![]() The Wrong Kind of Rights:The Charter Threat to Medicare From: Medicare |
Examines the threat that the charter presents to medicare and the people’s place in influencing medicare decisions | Andrew Petter | 7 | 2007 | $0.70 Add |
|
From ![]() Whose Child Is This?“Surrogacy,” Authority, and Responsibility From: Surrogacy in Canada |
In Chapter 1, Christine Overall, while accepting that the practice of surrogacy may be here to stay, considers the troubling moral issues that arise with respect to women who act as surrogates … | Christine Overall | 21 | 2018 | $2.10 Add |
|
From ![]() “Why We Don’t Know What We Don’t Know” About Canada’s Surrogacy Practices and OutcomesFrom: Surrogacy in Canada |
We know very little about the lived experiences of women who act as surrogates, the intended parents, and the children conceived as a result of surrogacy arrangements. Pamela M White, in Chapter … | Pamela M White | 30 | 2018 | $3.00 Add |






